Core Insights - The article highlights a significant growth forecast for 2024, with a projected increase of 10.70% [1] - The anticipated revenue for the year is estimated at 2265 million [1] - A notable profit margin of 43.55% is expected, indicating strong operational efficiency [1] Financial Metrics - The expected growth rate for 2024 stands at 10.70% [1] - The projected revenue for 2024 is 2265 million [1] - The profit margin is forecasted to be 43.55% [1] - An additional metric shows a profit increase of 13.79% [1]

■■■■■300908■■■■2025■■■■■■■■2.77■■■■■■■1.06%■■■■■4841.85■■■■■■■4.81%■ ...

红宝丽（002165）跌停价开盘，公司第一季度净利润同比下降24%。 ...

中新集团（601512）公告，2024年营业收入为26.85亿元，同比下降26.57%。归属于上市公司股东的净 利润为6.37亿元，同比下降53.22%。公司拟以实施权益分派股权登记日登记的总股本基数，向全体股东 每10股派发现金股利人民币1.28元(含税)，预计共计分配股利1.92亿元，占当年度合并归属于上市公司 股东净利润的30.11%。本年度不送红股也不实施资本公积金转增股本。 ...

四川美丰（000731）公告，2024年营业收入45.54亿元，同比增长9.10%。归属于上市公司股东的净利润 2.72亿元，同比下降28.97%。基本每股收益0.4791元/股，同比下降27.32%。公司拟向全体股东每10股派 发现金红利1.7元(含税)，送红股0股(含税)，不以公积金转增股本。 ...

Core Viewpoint - The company Guifaxiang (002820) expects a significant decline in net profit for the first quarter of 2025, projecting a profit of 6 to 7 million yuan, which represents a year-on-year decrease of 67.91% to 62.56% [1] Financial Summary - The projected net profit for the first quarter of 2025 is between 6 million and 7 million yuan [1] - This represents a decline of approximately 67.91% to 62.56% compared to the same period last year [1]

二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 59843.09万股，累计占流通股比： 72.85%，较上期变化： -895.25万 股。 | 名称 持有数量(万股) | | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 香港中央结算(代理人)有限公司 | 28422.58 | 34.60 | 2.90 | | 上海复旦复控科技产业控股有限公司 | 10962.00 | 13.35 | 不变 | | 上海复芯凡高集成电路技术有限公司 | 10673.00 | 12.99 | 不变 | | 上海政本企业管理咨询合伙企业(有限合伙) | 3568.20 | 4.34 | 不变 | | 华夏上证科创板50成份ETF | 2142.13 | 2.61 | -310.00 | | 易方达上证科创板50ETF | 1342.68 | 1.63 | -159.69 | | 施雷 | 721.00 | 0.88 | 不变 | | 蒋国兴 | 721.00 | 0.88 | 不变 | | 嘉实上证科创板芯片ETF | 690.50 | 0.84 | 新进 | ...

Core Viewpoint - Shenyang Chemical's net profit for 2024 decreased by 77.57%, while revenue increased by 4.08%, indicating significant challenges in profitability despite a slight growth in sales [3][4]. Financial Performance - The company reported a revenue of 13.97 billion yuan in 2024, up from 13.42 billion yuan in 2023, reflecting a year-on-year growth of 4.08% [4]. - The net profit attributable to shareholders was 33.53 million yuan, a sharp decline from 149.46 million yuan in the previous year, marking a decrease of 77.57% [4]. - The company experienced a non-operating loss of 92.40 million yuan, which is a 204.80% increase in losses compared to the previous year [3][4]. Factors Affecting Profitability - The decline in net profit was attributed to several factors, including: - A reduction in profit of 19.47 million yuan due to changes in sales volume and product prices [4]. - An increase in sales expenses leading to a loss of 0.22 million yuan [4]. - A decrease in research and development expenses resulting in a loss of 4.12 million yuan [4]. - A decrease in investment income leading to a loss of 3.30 million yuan [4]. - Other factors contributing to losses included credit impairment losses and asset impairment losses [4]. Future Plans - The company plans to invest in a new production base in Thailand, focusing on a 20,000 tons/year nylon 66 differentiated fiber project [5]. - The initial registered capital for the subsidiary in Thailand is set at 500,000 Thai Baht, with Shenyang Chemical contributing 70% of the capital [5][6].